Curis Lifesciences Reports Zero Deviation in IPO Proceeds Utilization as of Sep'26
Curis Lifesciences Ltd · Others (Uncategorized) · 11 Nov 2026, 9:39 pm
Curis Lifesciences Reports Zero Deviation in IPO Proceeds Utilization as of Sep'26 Curis Lifesciences Limited reported nil deviation in the utilization of funds raised via its SME IPO for the half-year ended 30th Sep'26. Out of the total ₹27.52 crore raised across 21.50 lakh equity shares at ₹128 each, the company has deployed ₹22.95 crore, leaving ₹5.37 crore unutilized. Key deployments include full utilization of ₹11.25 crore for working capital, ₹3.39 crore of ₹3.62 crore allocated for storage facility capex, ₹1.82 crore for debt repayment, and ₹2.89 crore toward general corporate purposes.
Original exchange filing (PDF)
More announcements from Curis Lifesciences Ltd
- Curis Lifesciences Limited has informed the Exchange regarding 'Standalone andconsolidated financials results for the half year ended on 30th September, 2026'. · 16 Nov 2026
- Curis Lifesciences Limited has submitted to the Exchange, the standalone and consolidated financial results for the half year ended September 30, 2026. · 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 11 Nov 2026
- Curis Lifesciences Limited has informed the Exchange about the Board meeting to be held on 11th November, 2026 to consider and approve the unaudited Standalone and Consolidated financial results for the half year ended on September 30, 2026 · 11 Nov 2026
- Curis Lifesciences Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Quarter and year ended on September 30, 2026 · 19 Oct 2026
- Curis Lifesciences Limited has submitted the Exchange a copy Srutinizers report of 10th Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results. · 01 Oct 2026
- CURIS: Curis Lifesciences Limited has informed the Exchange regarding Proceedings of 10thAnnual General Meeting held on September 29, 2026. · 30 Sept 2026
- Curis Lifesciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026 · 08 Sept 2026
